Driehaus Capital Management LLC

Position in CLDX — Celldex Therapeutics, Inc.

CIK 938206 Chicago, IL

Position in CLDX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$36,817,136

+$26,861,671 QoQ

Shares Held

989,442

+238.5% QoQ

Ownership

1.26%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#22

of 252 holders

Holding Since

Jun 2020

9 quarters on record

Voting authority Sole 78% Shared 0% None 22%

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,602,052,293 across 59 Biotechnology names. CLDX ranks #22 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc.	6,845,276	$322,001,783
2	PRAX	Praxis Precision Medicines, Inc.	959,048	$321,079,679
3	XENE	Xenon Pharmaceuticals Inc.	4,418,557	$266,704,100
4	SYRE	Spyre Therapeutics, Inc.	2,799,166	$248,509,957
5	CRNX	Crinetics Pharmaceuticals, Inc.	6,463,551	$241,866,078
6	APGE	Apogee Therapeutics, Inc.	1,740,101	$230,963,605
7	EWTX	Edgewise Therapeutics, Inc.	4,728,623	$192,123,952
8	SEPN	Septerna, Inc.	4,433,058	$148,463,112

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$36,817,136	989,442	+238.5%	Shares	Sole	2026-08-14
2022-03-31	$9,955,465	292,292	-43.3%	Shares	Sole	2022-05-16
2021-12-31	$19,918,494	515,489	-6.5%	Shares	Sole	2022-02-14
2021-09-30	$29,751,999	551,065	-5.9%	Shares	Sole	2021-11-15
2021-06-30	$19,572,799	585,311	+67.8%	Shares	Sole	2021-08-16
2021-03-31	$7,186,104	348,840	-11.3%	Shares	Sole	2021-05-17
2020-12-31	$6,889,126	393,215	-2.1%	Shares	Sole	2021-02-16
2020-09-30	$5,958,145	401,763	+234.8%	Shares	Sole	2020-11-16
2020-06-30	$1,560,000	120,000	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.